Cargando…
Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC
BACKGROUND: Solute carrier family 7 member 2 (SLC7A2), a cationic amino acid transporter, is lowly expressed in ovarian and hepatocellular cancers, which is associated with their worse prognosis. However, its roles in the prognosis, drug resistance and immune infiltration in non-small-cell lung canc...
Autores principales: | Jiang, Shanshan, Zou, Junrong, Dong, Jianyu, Shi, Huimian, Chen, Jie, Li, Yan, Duan, Xianglong, Li, Wensheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838041/ https://www.ncbi.nlm.nih.gov/pubmed/36639771 http://dx.doi.org/10.1186/s12964-022-01023-x |
Ejemplares similares
-
Metachronous Brain Metastasis in patients with EGFR-mutant NSCLC indicates a worse prognosis
por: Ouyang, Wen, et al.
Publicado: (2020) -
Why less is worse for lupus
por: Bashyam, Hema
Publicado: (2008) -
Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
por: Ye, Chenyang, et al.
Publicado: (2022) -
Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma
por: Li, Yao, et al.
Publicado: (2023) -
Are adolescents sleeping less and worse than before?
por: Chan, Ngan Yin, et al.
Publicado: (2021)